Clinical Trial Update: Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for chidamide-based targeted therapy in adult T-cell lymphoblastic leukemia/lymphoma (T-LBL/ALL), spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma
• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Leukemia, Leukemia, Acute | Phase 2, Phase 3 | Status: UNKNOWN